Background
==========

Cyclo-oxygenase (COX) is the rate-limiting enzyme in converting arachidonic acid to prostaglandins. There are two isoforms of COX: COX-1, which is expressed in many tissues; and COX-2, which is the inducible form. COX-2 has been reported to be involved in carcinogenesis and tumour angiogenesis. Therefore, we hypothesized that COX-2 expression was associated with that of vascular endothelial growth factor (VEGF) and proliferating cell nuclear antigen (PCNA) in human breast cancer.

Materials and method
====================

RNA was extracted from 15 human breast carcinomas and adjacent noncancerous tissue (ANCT). COX-2, VEGF189 and PCNA expressions were estimated by reverse transcriptase-PCR (RT-PCR) and Taqman methodology in the RNA samples. The results were analyzed using Spearman\'s correlation with Student\'s *t*-test.

Results
=======

Median mRNA copy number for PCNA mRNA in tumours was 1.65 × 10^6^ (range 3.79 × 10^5^-1.46 × 10^7^). For COX-2, the median mRNA copy number was 4.56 × 10^5^ (range 2.48 × 10^3^-5.10 × 10^6^) in tumours and 2.26 × 10^6^(range 1.37E+05-4.79E+07) in ANCT. Copy numbers of VEGF mRNA in tumours had a median value of 2.13 × 10^6^ (range 3.42 × 10^1^-3.37 × 10^7^). There was a highly significant correlation between COX-2 and PCNA levels in tumours (r\'s = 0.7896; *P* = 0.000001) and VEGF in tumour samples (r\'s = 0.4610; 2 *P* = 0.0320).

Conclusion
==========

COX-2 expression is significantly associated with increased cellular proliferation and angiogenesis in invasive breast cancer. The upregulation of COX-2 in ANCT suggests that COX-2 in the host is relevant to mammary carcinogenesis.
